First finding from Pfizer trials

A texan court ordered that the FDA release the documents used by the FDA to give emergency use authorisation for the Pfizer vaccine. The FDA asked if these documents could be kept hidden until 2076 but by August all will have been shared. Early analysis has demonstrated several concerning anomalies but crucially it has revealed that the efficacy data was not what was sold.

Read More

Second Open Letter to all members of the FDA vaccines committee

We are a group of health professionals and scientists from the UK, who submitted a letter to the FDA meeting in March regarding our concerns over the potential authorisation of Pfizer vaccine for children aged 6 months to 4 years and our letter is reattached today in readiness for your June meeting.  No new evidence has come to light since our March letter, which gives any credibility to the necessity, safety or even efficacy of this vaccine for infants. 

Read More

How to measure vaccine harms

Drug harm reporting systems, like the MHRA’s yellow card system, are designed to alert the regulator to a potential issue. They are not designed to measure the size of the problem. If an issue is highlighted then the regulator has a responsibility to carry out an audit and see whether the incidence of the condition of concern has been higher than historical levels in the population who were vaccinated.

Read More

Vaccine Damage: the human cost of rushed-to-market products

The existing mechanism for compensating those suffering vaccine damage was set up in 1979. If the vaccination caused ‘severe disablement’ (classed, somewhat callously, as being ‘60% disabled’), then one can become eligible for a one-off payment of £120,000, but only if you are able to undergo an excruciating and protracted battle with the authorities to have your claim accepted.

Read More

Children’s covid vaccines: it’s all about balance of risks…

Over many months, a group of experienced health professionals and academics have been writing to the MHRA and the JCVI regarding the vaccination of healthy children, with most of the letters posted on the HART website. In our most recent letter, the authors have called for a pause to the children’s vaccine rollout pending a thorough investigation of a number of safety concerns. 

Read More